Evidence map›Paper›PMID 29935081›Full record

ArticleMedical physics2018

Interstitial assessment of aggressive prostate cancer by physio-chemical photoacoustics: An ex vivo study with intact human prostates.

Shengsong Huang, Yu Qin, Yingna Chen, Jing Pan, Chengdang Xu, Denglong Wu, Wan-Yu Chao, John T Wei, Scott A Tomlins, Xueding Wang and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Medical physics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

Shengsong HuangDepartment of Urology, Tongji Hospital, Tongji University School of Medicine, Shanghai, 200065, China.
Yu QinInstitute of Acoustics, School of Physics Science and Engineering, Tongji University, Shanghai, 200092, China.
Yingna ChenInstitute of Acoustics, School of Physics Science and Engineering, Tongji University, Shanghai, 200092, China.
Jing PanInstitute of Acoustics, School of Physics Science and Engineering, Tongji University, Shanghai, 200092, China.
Chengdang XuDepartment of Urology, Tongji Hospital, Tongji University School of Medicine, Shanghai, 200065, China.
Denglong WuDepartment of Urology, Tongji Hospital, Tongji University School of Medicine, Shanghai, 200065, China.
Wan-Yu ChaoFaculty of Science, University of Western Ontario, London, ON, N6A 3K7, Canada.
John T WeiDepartement of Urology, University of Michigan, Ann Arbor, 48109, USA.
Scott A TomlinsDepartement of Pathology, University of Michigan, Ann Arbor, 48109, USA.
Xueding WangDepartement of Radiology, University of Michigan, Ann Arbor, 48109, USA.
J Brian FowlkesDepartement of Radiology, University of Michigan, Ann Arbor, 48109, USA.
Paul L CarsonDepartement of Radiology, University of Michigan, Ann Arbor, 48109, USA.
Qian ChengInstitute of Acoustics, School of Physics Science and Engineering, Tongji University, Shanghai, 200092, China.
Guan XuDepartment of Urology, Tongji Hospital, Tongji University School of Medicine, Shanghai, 200065, China.
Tongji University · CNUniversity of Michigan–Ann Arbor · USInstitute of Acoustics · CNTongji Hospital · CNWestern University · CA

Funding

Physiology of Inflammatory Arthritis in High ResolutionR01AR060350 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WANG, XUEDING · 2011 to 2021
$6.0M
In vivo photoacoustic biopsy for intestinal strictures in Crohn's diseaseR21AI122098 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HIGGINS, PETER D.R., XU, GUAN · 2016 to 2017
$397k
NIAID NIH HHS R21 AI122098NIAMS NIH HHS R01 AR060350
6 · The paper itself

Abstract

purposeTransrectal ultrasound (TRUS)-guided biopsy is the standard procedure for evaluating the presence and aggressiveness of prostate cancer. TRUS biopsy involves tissue removal, and suffers from low core yield as well as high false negative rate. A less invasive and more accurate diagnostic procedure for prostate cancer is therefore highly desired. Combining the optical sensitivity and ultrasonic resolution to resolve the spatial distribution of the major molecular components in tissue, photoacoustic (PA) technology could be an alternative approach for the diagnosis of prostate cancer. The purpose of this study was to examine the feasibility of identifying aggressive prostate cancer using interstitial PA measurements.

methodsSeventeen patients with prebiopsy magnetic resonance imaging (MRI), TRUS biopsies, and planned prostatectomies were enrolled in this study. The interstitial PA measurements were achieved using our recently developed needle PA probe, which was inserted into the ex vivo prostates in the fashion of a biopsy needle. A total of 70 interstitial PA measurements were acquired. The PA measurements were quantified by a previously established PA physio-chemical analysis (PAPCA) method. The histology has confirmed the nonaggressive and aggressive cancerous conditions at the insertion locations. The diagnostic accuracy was also compared to that provided by the prebiopsy MRI.

resultsThe quantitative study shows significant differences between the individual parameters of the nonaggressive and the aggressive cancerous regions (P < 0.005). Multivariate analysis of the quantitative features achieved a diagnostic accuracy of 78.6% for differentiating nonaggressive and aggressive prostate cancer tissues.

conclusionsThe proposed procedure has shown promises in the diagnosis of aggressive prostate cancer.

Indexed as

medical imagingoptoacousticsphotoacoustic physio-chemical analysisphotoacoustic spectral analysisprostate cancer

Identifiers

PMID29935081
PMCPMC6629517
OpenAlexW2810469822

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.